Device
Cerviron®
Cerviron® is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Phase Distribution
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Clinical Investigation To Evaluate Cerviron Ovules® in Symptomatic Vaginitis
NCT04735705
completed
Real-world Performance and Safety of Cerviron® in the Treatment of Vaginitis
NCT05652959
completednot_applicable
Clinical Investigation To Evaluate Cerviron Ovules® in Cervix Lesions Postoperative Care
NCT04735718
completed
RWE Study in the Treatment of Cervical Lesions of Various Etiology
NCT05668806
Clinical Trials (4)
Showing 4 of 4 trials
NCT04735705Not Applicable
Clinical Investigation To Evaluate Cerviron Ovules® in Symptomatic Vaginitis
NCT05652959
Real-world Performance and Safety of Cerviron® in the Treatment of Vaginitis
NCT04735718Not Applicable
Clinical Investigation To Evaluate Cerviron Ovules® in Cervix Lesions Postoperative Care
NCT05668806
RWE Study in the Treatment of Cervical Lesions of Various Etiology
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4